U.S. Allergy and Autoimmune Disease Diagnostics Market Size Worth USD 9.56 Billion by 2034 | CAGR: 8.5%

The U.S. allergy and autoimmune disease diagnostics market size is expected to reach USD 9.56 billion by 2034, according to a new study by Polaris Market Research. The report “U.S. Allergy and Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report By Products & Services (Allergy Diagnostics, Autoimmune Disease Diagnostics), By Test Type, By Diagnostics Type, By End Use – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The U.S. market for allergy and autoimmune disease diagnostics involves a range of tests and services. These are designed to identify and monitor conditions where the immune system is not working correctly. This includes allergies, which are an overreaction to harmless things in the environment, and autoimmune diseases, where the immune system attacks the body's own healthy tissues. The products in this market can be as simple as blood tests or as advanced as genetic sequencing.

The U.S. allergy and autoimmune disease diagnostics market is highly competitive. Companies are trying to create more accurate and effective diagnostic tools. The goal is to provide fast and reliable results that help doctors make the right decisions about a patient's care. The overall market is seeing growth owing to the high prevalence of these conditions, a greater focus on early diagnosis, and ongoing improvements in testing technology.

Have Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/us-allergy-and-autoimmune-disease-diagnostics-market/request-for-sample

U.S. Allergy and Autoimmune Disease Diagnostics Market Report Highlights:

• Based on product & services, the allergy diagnostics segment held the largest share in 2024. due to the increasing prevalence of conditions such as asthma, allergic rhinitis, and food allergies.
• Based on test type, the allergy diagnostics segment held the largest share in 2024. due to the wide use of diagnostic tests that identify common allergens.
• Based on diagnostics type, the allergy diagnostics segment held the largest share in 2024, as there is a rise in public awareness and a growing requirement for allergy identification.
• Based on end use, the allergy diagnostics segment held the largest share in 2024, due to their large patient volumes and access to advanced equipment.
• A few key players in the U.S. allergy and autoimmune disease diagnostics market include Abbott Laboratories, Bio-Rad Laboratories, Quest Diagnostics, Siemens Healthineers AG (Siemens AG), Thermo Fisher Scientific (Phadia AB), and Grifols S.A. Other companies like bioMérieux SA, Trinity Biotech plc, Werfen, and EUROIMMUN Medizinische Labordiagnostika AG.

Polaris Market Research has segmented the U.S. allergy and autoimmune disease diagnostics market report based on products & services, test type, diagnostics type, and end use:

By Products & Services Outlook (Revenue – USD Billion, 2020–2034)

• Allergy Diagnostics
  • Instruments
  • Consumables
  • Services
• Autoimmune Disease Diagnostics
  • Instruments
  • Consumables
  • Services

By Test Type Outlook (Revenue – USD Billion, 2020–2034)

• Allergy Diagnostics
  • In vivo Test
    • Skin Prick Test
    • Intradermal Test
    • Patch Test
  • In vitro Test
• Autoimmune Disease Diagnostics
  • Antinuclear Antibody Tests
  • Autoantibody Tests
  • C-reactive Protein (CRP)
  • Complete Blood Count (CBC)
  • Urinalysis
  • Others

By Diagnostics Type Outlook (Revenue – USD Billion, 2020–2034)

• Allergy Diagnostics
  • Food
    • Dairy Products
    • Poultry Product
    • Tree Nuts
    • Peanuts
    • Shellfish
    • Wheat
    • Soys
    • Other Food Allergens
  • Inhaled
  • Drug
  • Other Allergens
• Autoimmune Disease Diagnostics
  • Systemic Autoimmune Disease Diagnostics
    • Rheumatoid Arthritis
    • Ankylosing Spondylitis
    • Systemic Lupus Erythematosus (SLE)
    • Others
  • Localized Autoimmune Disease Diagnostics
    • Multiple Sclerosis
    • Type 1 Diabetes
    • Hashimoto's Thyroiditis
    • Idiopathic Thrombocytopenic Purpura
    • Others

By End Use Outlook (Revenue – USD Billion, 2020–2034)

• Allergy Diagnostics
  • Hospitals & Clinics
  • Diagnostics Laboratories
  • Research Institutions
  • Others
• Autoimmune Disease
  • Hospitals & Clinics
  • Diagnostics Laboratories
  • Research Institutions
  • Others